{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:32:16Z","timestamp":1793817136263,"version":"4.6.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903689, 81903683, 82073906, 82473983"],"award-info":[{"award-number":["81903689, 81903683, 82073906, 82473983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903689, 81903683, 82073906, 82473983"],"award-info":[{"award-number":["81903689, 81903683, 82073906, 82473983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903689, 81903683, 82073906, 82473983"],"award-info":[{"award-number":["81903689, 81903683, 82073906, 82473983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903689, 81903683, 82073906, 82473983"],"award-info":[{"award-number":["81903689, 81903683, 82073906, 82473983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postgraduate Research Practice Innovation Program of Jiangsu Province","award":["SJCX25_1546"],"award-info":[{"award-number":["SJCX25_1546"]}]},{"name":"Postgraduate Research Practice Innovation Program of Jiangsu Province","award":["No. KYCX21-2733"],"award-info":[{"award-number":["No. KYCX21-2733"]}]},{"name":"Postgraduate Research Practice Innovation Program of Jiangsu Province","award":["KYCX25_3256"],"award-info":[{"award-number":["KYCX25_3256"]}]},{"name":"Xuzhou Pengcheng Talents-Young Medical Reserve Talents","award":["XWRCHT20220034"],"award-info":[{"award-number":["XWRCHT20220034"]}]},{"name":"China Health & Medical Development Foundation","award":["XYFY202407120875"],"award-info":[{"award-number":["XYFY202407120875"]}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241958"],"award-info":[{"award-number":["BK20241958"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241957"],"award-info":[{"award-number":["BK20241957"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The initializing Fund of Xuzhou Medical University","award":["D2018011"],"award-info":[{"award-number":["D2018011"]}]},{"DOI":"10.13039\/501100013088","name":"Qinglan Project of Jiangsu Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00824-5","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:12:44Z","timestamp":1762863164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of intestinal SCFAs homeostasis in the hepatoprotective effect of Clostridium butyricum in T2DM"],"prefix":"10.1038","volume":"11","author":[{"given":"Meng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pian","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"824_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jhep.2023.01.014","volume":"78","author":"A Falkevall","year":"2023","unstructured":"Falkevall, A. et al. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue. J. Hepatol. 78, 901\u2013913 (2023).","journal-title":"J. Hepatol."},{"key":"824_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"824_CR3","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren, J. & Scheja, L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol. Metab. 50, 101238 (2021).","journal-title":"Mol. Metab."},{"key":"824_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher, G., Corey, K. E., Byrne, C. D. & Roden, M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol. 18, 599\u2013612 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"824_CR5","doi-asserted-by":"publisher","first-page":"159209","DOI":"10.1016\/j.bbalip.2022.159209","volume":"1867","author":"CC Hughey","year":"2022","unstructured":"Hughey, C. C., Puchalska, P. & Crawford, P. A. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1867, 159209 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"824_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/CM9.0000000000003230","volume":"138","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Oxidative stress in diabetes mellitus and its complications: From pathophysiology to therapeutic strategies. Chin. Med. J. (Engl.) 138, 15\u201327 (2025).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"824_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10517-021-05191-7","volume":"171","author":"MA Darenskaya","year":"2021","unstructured":"Darenskaya, M. A., Kolesnikova, L. I. & Kolesnikov, S. I. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull. Exp. Biol. Med. 171, 179\u2013189 (2021).","journal-title":"Bull. Exp. Biol. Med."},{"key":"824_CR8","doi-asserted-by":"publisher","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","volume":"328","author":"MS Kuchay","year":"2025","unstructured":"Kuchay, M. S., Choudhary, N. S. & Ramos-Molina, B. Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease. Am. J. Physiol. Cell Physiol. 328, C1637\u2013c1666 (2025).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"824_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg, G. R., Valvano, C. M., De Nardo, W. & Watt, M. J. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms. J. Hepatol. 83, 584\u2013595 (2025).","journal-title":"J. Hepatol."},{"key":"824_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113888","volume":"176","author":"V Kumar","year":"2021","unstructured":"Kumar, V. et al. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv. Drug Deliv. Rev. 176, 113888 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"824_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase, D. M. et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J. Diabetes Res. 2020, 3920196 (2020).","journal-title":"J. Diabetes Res."},{"key":"824_CR12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2024.0046","volume":"331","author":"K Suissa","year":"2024","unstructured":"Suissa, K., Cromer, S. J. & Patorno, E. GLP-1 receptor agonists and gastrointestinal adverse events. Jama 331, 884\u2013885 (2024).","journal-title":"Jama"},{"key":"824_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida, Y. & Yoneda, M. Current and future pharmacological therapies for NAFLD\/NASH. J. Gastroenterol. 53, 362\u2013376 (2018).","journal-title":"J. Gastroenterol."},{"key":"824_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct. Target Ther. 7, 287 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"824_CR15","doi-asserted-by":"publisher","first-page":"104821","DOI":"10.1016\/j.ebiom.2023.104821","volume":"97","author":"L Crudele","year":"2023","unstructured":"Crudele, L., Gadaleta, R. M., Cariello, M. & Moschetta, A. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine 97, 104821 (2023).","journal-title":"EBioMedicine"},{"key":"824_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2108655","volume":"14","author":"A Nabavi-Rad","year":"2022","unstructured":"Nabavi-Rad, A. et al. The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes 14, 2108655 (2022).","journal-title":"Gut Microbes"},{"key":"824_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12866-024-03218-3","volume":"24","author":"HMU Tayyib","year":"2024","unstructured":"Tayyib, H. M. U. et al. Restoration of gut dysbiosis through clostridium butyricum and magnesium possibly balance blood glucose levels: an experimental study. BMC Microbiol. 24, 105 (2024).","journal-title":"BMC Microbiol."},{"key":"824_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4093\/dmj.2023.0109","volume":"48","author":"T Zhou","year":"2024","unstructured":"Zhou, T. et al. Supplementation of clostridium butyricum alleviates vascular inflammation in diabetic mice. Diabetes Metab. J. 48, 390\u2013404 (2024).","journal-title":"Diabetes Metab. J."},{"key":"824_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.14715\/cmb\/2021.67.5.9","volume":"68","author":"W Zhu","year":"2022","unstructured":"Zhu, W., Yan, M., Cao, H., Zhou, J. & Xu, Z. Effects of clostridium butyricum capsules combined with rosuvastatin on intestinal flora, lipid metabolism, liver function and inflammation in NAFLD patients. Cell Mol. Biol. (Noisy-le.-Gd.) 68, 64\u201369 (2022).","journal-title":"Cell Mol. Biol. (Noisy-le.-Gd.)"},{"key":"824_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01368-22","volume":"10","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis. Microbiol. Spectr. 10, e0136822 (2022).","journal-title":"Microbiol. Spectr."},{"key":"824_CR21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3389\/fimmu.2017.01345","volume":"8","author":"L Jia","year":"2017","unstructured":"Jia, L. et al. Clostridium butyricum CGMCC0313.1 protects against autoimmune diabetes by modulating intestinal immune homeostasis and inducing pancreatic regulatory T cells. Front. Immunol. 8, 1345 (2017).","journal-title":"Front. Immunol."},{"key":"824_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-018-0762-0","volume":"17","author":"X Zhu","year":"2018","unstructured":"Zhu, X. et al. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression. Lipids Health Dis. 17, 114 (2018).","journal-title":"Lipids Health Dis."},{"key":"824_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 802\u2013816 (2016).","journal-title":"Immunity"},{"key":"824_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12020-016-1032-4","volume":"54","author":"F Xiong","year":"2016","unstructured":"Xiong, F. et al. TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-\u03b21 in rat glomerular mesangial cells by inhibiting RhoA\/ROCK signaling. Endocrine 54, 657\u2013670 (2016).","journal-title":"Endocrine"},{"key":"824_CR25","doi-asserted-by":"publisher","first-page":"10675","DOI":"10.1039\/D0FO01954B","volume":"11","author":"T Yang","year":"2020","unstructured":"Yang, T. et al. Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db\/db mice. Food Funct. 11, 10675\u201310689 (2020).","journal-title":"Food Funct."},{"key":"824_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.652942","volume":"12","author":"H Wibowo","year":"2021","unstructured":"Wibowo, H. et al. Impact of sodium butyrate treatment in LPS-stimulated peripheral blood mononuclear cells of poorly controlled type 2 DM. Front. Endocrinol. (Lausanne) 12, 652942 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"824_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.12.005","volume":"14","author":"B Li","year":"2024","unstructured":"Li, B. et al. Traditional Chinese medicine Pien-Tze-Huang ameliorates LPS-induced sepsis through bile acid-mediated activation of TGR5-STAT3-A20 signalling. J. Pharm. Anal. 14, 100915 (2024).","journal-title":"J. Pharm. Anal."},{"key":"824_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00374-8","volume":"9","author":"C Zhao","year":"2023","unstructured":"Zhao, C. et al. Gut microbiota-mediated secondary bile acid alleviates Staphylococcus aureus-induced mastitis through the TGR5-cAMP-PKA-NF-\u03baB\/NLRP3 pathways in mice. NPJ Biofilms Microbiomes 9, 8 (2023).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"824_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48288-z","volume":"15","author":"SZ Li","year":"2024","unstructured":"Li, S. Z. et al. CLK2 mediates I\u03baB\u03b1-independent early termination of NF-\u03baB activation by inducing cytoplasmic redistribution and degradation. Nat. Commun. 15, 3901 (2024).","journal-title":"Nat. Commun."},{"key":"824_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112586","volume":"42","author":"X Fei","year":"2023","unstructured":"Fei, X. et al. The Scap-SREBP1-S1P\/S2P lipogenesis signal orchestrates the homeostasis and spatiotemporal activation of NF-\u03baB. Cell Rep. 42, 112586 (2023).","journal-title":"Cell Rep."},{"key":"824_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1097-2765(04)00216-3","volume":"14","author":"H Gao","year":"2004","unstructured":"Gao, H. et al. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14, 303\u2013317 (2004).","journal-title":"Mol. Cell"},{"key":"824_CR32","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1073\/pnas.0402851101","volume":"101","author":"DS Witherow","year":"2004","unstructured":"Witherow, D. S., Garrison, T. R., Miller, W. E. & Lefkowitz, R. J. beta-arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. USA 101, 8603\u20138607 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"824_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J. Hepatol. 71, 793\u2013801 (2019).","journal-title":"J. Hepatol."},{"key":"824_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3201\/eid3004.231633","volume":"30","author":"RM Sada","year":"2024","unstructured":"Sada, R. M. et al. Clostridium butyricum bacteremia associated with probiotic use, Japan. Emerg. Infect. Dis. 30, 665\u2013671 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"824_CR35","doi-asserted-by":"publisher","DOI":"10.1590\/acb370904","volume":"37","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. The protective effects of dietary Clostridium butyricum supplementation on hepatic ischemia reperfusion injury in rats. Acta Cir. Bras. 37, e370904 (2022).","journal-title":"Acta Cir. Bras."},{"key":"824_CR36","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1039\/C7FO00355B","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. The hepatoprotective effect of the probiotic clostridium butyricum against carbon tetrachloride-induced acute liver damage in mice. Food Funct. 8, 4042\u20134052 (2017).","journal-title":"Food Funct."},{"key":"824_CR37","doi-asserted-by":"publisher","first-page":"1113643","DOI":"10.3389\/fcimb.2023.1113643","volume":"13","author":"LT Jin","year":"2023","unstructured":"Jin, L. T. & Xu, M. Z. Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease. Front Cell Infect. Microbiol. 13, 1113643 (2023).","journal-title":"Front Cell Infect. Microbiol."},{"key":"824_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07335-0","volume":"7","author":"L Jia","year":"2017","unstructured":"Jia, L. et al. Anti-diabetic effects of clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrate-producing bacteria in type 2 diabetic mice. Sci. Rep. 7, 7046 (2017).","journal-title":"Sci. Rep."},{"key":"824_CR39","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jgh.13742","volume":"32","author":"D Zhou","year":"2017","unstructured":"Zhou, D. et al. Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation. J. Gastroenterol. Hepatol. 32, 1640\u20131648 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"824_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/biomedicines10020483","volume":"10","author":"T Ariyoshi","year":"2022","unstructured":"Ariyoshi, T., Hagihara, M., Takahashi, M. & Mikamo, H. Effect of clostridium butyricum on gastrointestinal infections. Biomedicines 10, 483 (2022).","journal-title":"Biomedicines"},{"key":"824_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155056","volume":"120","author":"M Zhao","year":"2023","unstructured":"Zhao, M. et al. Paeonol alleviates ulcerative colitis in mice by increasing short-chain fatty acids derived from clostridium butyricum. Phytomedicine 120, 155056 (2023).","journal-title":"Phytomedicine"},{"key":"824_CR42","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s10620-023-07835-2","volume":"68","author":"Y Choi","year":"2023","unstructured":"Choi, Y. et al. Effect of clostridium butyricum on high-fat diet-induced intestinal inflammation and production of short-chain fatty acids. Dig. Dis. Sci. 68, 2427\u20132440 (2023).","journal-title":"Dig. Dis. Sci."},{"key":"824_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1124118","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang, F. et al. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease. Front. Immunol. 14, 1124118 (2023).","journal-title":"Front. Immunol."},{"key":"824_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1076245","volume":"13","author":"W Cao","year":"2022","unstructured":"Cao, W. et al. Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy. Front. Immunol. 13, 1076245 (2022).","journal-title":"Front. Immunol."},{"key":"824_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47273-w","volume":"15","author":"P Liu","year":"2024","unstructured":"Liu, P. et al. Immunoregulatory role of the gut microbiota in inflammatory depression. Nat. Commun. 15, 3003 (2024).","journal-title":"Nat. Commun."},{"key":"824_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37419-7","volume":"14","author":"P Tian","year":"2023","unstructured":"Tian, P. et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat. Commun. 14, 1710 (2023).","journal-title":"Nat. Commun."},{"key":"824_CR47","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.3390\/ijms242417554","volume":"24","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Clostridium butyricum ameliorates the effect of coprophagy prevention on hepatic lipid synthesis in rabbits via the gut-liver axis. Int. J. Mol. Sci. 24, 17554 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"824_CR48","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1099\/00207713-52-5-1615","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan, S. H., Hold, G. L., Barcenilla, A., Stewart, C. S. & Flint, H. J. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int. J. Syst. Evol. Microbiol. 52, 1615\u20131620 (2002).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"824_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12938\/bmfh.18-029","volume":"38","author":"R Shinohara","year":"2019","unstructured":"Shinohara, R. et al. Butyryl-CoA:acetate CoA-transferase gene associated with the genus Roseburia is decreased in the gut microbiota of Japanese patients with ulcerative colitis. Biosci. Microbiota Food Health 38, 159\u2013163 (2019).","journal-title":"Biosci. Microbiota Food Health"},{"key":"824_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva, M. K. et al. Butyrate-producing human gut symbiont, clostridium butyricum, and its role in health and disease. Gut Microbes 13, 1\u201328 (2021).","journal-title":"Gut Microbes"},{"key":"824_CR51","first-page":"2789","volume":"17","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. Acetic acid alleviates the inflammatory response and liver injury in septic mice by increasing the expression of TRIM40. Exp. Ther. Med. 17, 2789\u20132798 (2019).","journal-title":"Exp. Ther. Med."},{"key":"824_CR52","first-page":"188","volume":"4","author":"S Al-Daihan","year":"2015","unstructured":"Al-Daihan, S. & Bhat, R. S. Impact of propionic acid on liver damage in rats. Int. J. Mol. Cell Med. 4, 188\u2013195 (2015).","journal-title":"Int. J. Mol. Cell Med."},{"key":"824_CR53","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.intimp.2018.01.017","volume":"56","author":"N Li","year":"2018","unstructured":"Li, N. et al. Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 release. Int. Immunopharmacol. 56, 242\u2013248 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"824_CR54","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1159\/000490981","volume":"47","author":"W Feng","year":"2018","unstructured":"Feng, W. et al. Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109a-dependent manner. Cell Physiol. Biochem. 47, 1617\u20131629 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"824_CR55","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1021\/acs.jafc.8b03108","volume":"66","author":"K Zhang","year":"2018","unstructured":"Zhang, K., Meng, M., Gao, L., Tu, Y. & Bai, Y. Sodium butyrate improves high-concentrate-diet-induced impairment of ruminal epithelium barrier function in goats. J. Agric. Food Chem. 66, 8729\u20138736 (2018).","journal-title":"J. Agric. Food Chem."},{"key":"824_CR56","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/mcp.RA118.000752","volume":"17","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and metabolic reprogramming. Mol. Cell Proteom. 17, 1531\u20131545 (2018).","journal-title":"Mol. Cell Proteom."},{"key":"824_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106657","volume":"85","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Sodium butyrate protects against oxidative stress in human nucleus pulposus cells via elevating PPAR\u03b3-regulated Klotho expression. Int Immunopharmacol. 85, 106657 (2020).","journal-title":"Int Immunopharmacol."},{"key":"824_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2020.12.003","volume":"32","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Liu, C., Jiang, Q. & Yin, Y. Butyrate in energy metabolism: there is still more to learn. Trends Endocrinol. Metab. 32, 159\u2013169 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"824_CR59","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/nu13082792","volume":"13","author":"YP Hsiao","year":"2021","unstructured":"Hsiao, Y. P. et al. Administration of lactobacillus reuteri combined with clostridium butyricum attenuates cisplatin-induced renal damage by gut microbiota reconstitution, increasing butyric acid production, and suppressing renal inflammation. Nutrients 13, 2792 (2021).","journal-title":"Nutrients"},{"key":"824_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1117905","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation. Front. Microbiol. 14, 1117905 (2023).","journal-title":"Front. Microbiol."},{"key":"824_CR61","doi-asserted-by":"publisher","first-page":"G340","DOI":"10.1152\/ajpgi.00440.2001","volume":"283","author":"V Marcil","year":"2002","unstructured":"Marcil, V. et al. Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G340\u2013G346 (2002).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"824_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jbt.21698","volume":"29","author":"G Kanika","year":"2015","unstructured":"Kanika, G., Khan, S. & Jena, G. Sodium butyrate ameliorates L-arginine-induced pancreatitis and associated fibrosis in wistar rat: role of inflammation and nitrosative stress. J. Biochem. Mol. Toxicol. 29, 349\u2013359 (2015).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"824_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep37589","volume":"6","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci. Rep. 6, 37589 (2016).","journal-title":"Sci. Rep."},{"key":"824_CR64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang, Y. D., Chen, W. D., Yu, D., Forman, B. M. & Huang, W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor \u03ba light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology 54, 1421\u20131432 (2011).","journal-title":"Hepatology"},{"key":"824_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/intimm\/dxab105","volume":"34","author":"J Rao","year":"2022","unstructured":"Rao, J. et al. Corrigendum to: deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the \u03b2-catenin destruction complex. Int. Immunol. 34, 53 (2022).","journal-title":"Int. Immunol."},{"key":"824_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","volume":"10","author":"C Thomas","year":"2009","unstructured":"Thomas, C. et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10, 167\u2013177 (2009).","journal-title":"Cell Metab."},{"key":"824_CR67","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. Sodium butyrate regulates macrophage polarization by TGR5\/\u03b2-arrestin2 in vitro. Mol. Med. 31, 31 (2025).","DOI":"10.1186\/s10020-025-01096-7"},{"key":"824_CR68","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/hep.29284","volume":"66","author":"TV Masyuk","year":"2017","unstructured":"Masyuk, T. V. et al. TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate\/G\u03b1s signaling. Hepatology 66, 1197\u20131218 (2017).","journal-title":"Hepatology"},{"key":"824_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","volume":"335","author":"JP Mitchell","year":"2018","unstructured":"Mitchell, J. P. & Carmody, R. J. NF-\u03baB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol. 335, 41\u201384 (2018).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"824_CR70","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","volume":"14","author":"TW Pols","year":"2011","unstructured":"Pols, T. W. et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 14, 747\u2013757 (2011).","journal-title":"Cell Metab."},{"key":"824_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115063","volume":"289","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5\/AKT\/NF-\u03baB signaling pathway. J. Ethnopharmacol. 289, 115063 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"824_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05764-w","volume":"22","author":"B Wen","year":"2024","unstructured":"Wen, B., Huang, Y., Deng, G., Yan, Q. & Jia, L. Gut microbiota analysis and LC-MS-based metabolomics to investigate AMPK\/NF-\u03baB regulated by clostridium butyricum in the treatment of acute pancreatitis. J. Transl. Med. 22, 1072 (2024).","journal-title":"J. Transl. Med."},{"key":"824_CR73","doi-asserted-by":"publisher","first-page":"106862","DOI":"10.1016\/j.intimp.2020.106862","volume":"88","author":"M Liu","year":"2020","unstructured":"Liu, M., Xie, W., Wan, X. & Deng, T. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice. Int. Immunopharmacol. 88, 106862 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"824_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1004756","volume":"14","author":"W Pu","year":"2023","unstructured":"Pu, W. et al. Inhibitory effects of clostridium butyricum culture and supernatant on inflammatory colorectal cancer in mice. Front. Immunol. 14, 1004756 (2023).","journal-title":"Front. Immunol."},{"key":"824_CR75","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30, 317\u2013325 (2018).","journal-title":"EBioMedicine"},{"key":"824_CR76","first-page":"670","volume":"7","author":"CG Carlson","year":"2015","unstructured":"Carlson, C. G., Dole, E., Stefanski, C. & Bayless, D. The effect of specific IKK\u03b2 inhibitors on the cytosolic expression of I\u03baB-\u03b1 and the nuclear expression of p65 in dystrophic (MDX) muscle. Am. J. Transl. Res. 7, 670\u2013682 (2015).","journal-title":"Am. J. Transl. Res."},{"key":"824_CR77","first-page":"898","volume":"18","author":"YC Qi","year":"2020","unstructured":"Qi, Y. C. et al. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway. Chin. J. Nat. Med. 18, 898\u2013906 (2020).","journal-title":"Chin. J. Nat. Med."},{"key":"824_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4939-2422-6_2","volume":"1280","author":"P Starokadomskyy","year":"2015","unstructured":"Starokadomskyy, P. & Burstein, E. Detection of I\u03baB degradation dynamics and I\u03baB-\u03b1 ubiquitination. Methods Mol. Biol. 1280, 15\u201324 (2015).","journal-title":"Methods Mol. Biol."},{"key":"824_CR79","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/biof.1083","volume":"39","author":"S Puangpraphant","year":"2013","unstructured":"Puangpraphant, S. et al. Yerba mate tea and mate saponins prevented azoxymethane-induced inflammation of rat colon through suppression of NF-\u03baB p65ser(311) signaling via I\u03baB-\u03b1 and GSK-3\u03b2 reduced phosphorylation. Biofactors 39, 430\u2013440 (2013).","journal-title":"Biofactors"},{"key":"824_CR80","doi-asserted-by":"publisher","first-page":"17882","DOI":"10.1016\/S0021-9258(19)37125-X","volume":"267","author":"H Attramadal","year":"1992","unstructured":"Attramadal, H. et al. Beta-arrestin2, a novel member of the arrestin\/beta-arrestin gene family. J. Biol. Chem. 267, 17882\u201317890 (1992).","journal-title":"J. Biol. Chem."},{"key":"824_CR81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.kint.2017.02.013","volume":"92","author":"H Noh","year":"2017","unstructured":"Noh, H. et al. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications. Kidney Int. 92, 101\u2013113 (2017).","journal-title":"Kidney Int."},{"key":"824_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1904609","volume":"2020","author":"T Zhao","year":"2020","unstructured":"Zhao, T. et al. Sodium butyrate-modulated mitochondrial function in high-insulin induced HepG2 cell dysfunction. Oxid. Med. Cell Longev. 2020, 1904609 (2020).","journal-title":"Oxid. Med. Cell Longev."},{"key":"824_CR83","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04479-22","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Butyrate protects against clostridium difficile infection by regulating bile acid metabolism. Microbiol. Spectr. 11, e0447922 (2023).","journal-title":"Microbiol. Spectr."},{"key":"824_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174341","volume":"908","author":"X Ye","year":"2021","unstructured":"Ye, X. et al. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism. Eur. J. Pharm. 908, 174341 (2021).","journal-title":"Eur. J. Pharm."},{"key":"824_CR85","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","volume":"1865","author":"D Jahn","year":"2019","unstructured":"Jahn, D., Kircher, S., Hermanns, H. M. & Geier, A. Animal models of NAFLD from a hepatologist\u2019s point of view. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 943\u2013953 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"824_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","volume":"68","author":"PK Santhekadur","year":"2018","unstructured":"Santhekadur, P. K., Kumar, D. P. & Sanyal, A. J. Preclinical models of non-alcoholic fatty liver disease. J. Hepatol. 68, 230\u2013237 (2018).","journal-title":"J. Hepatol."},{"key":"824_CR87","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1021\/acs.jafc.9b02083","volume":"67","author":"WQ Zhang","year":"2019","unstructured":"Zhang, W. Q. et al. Sodium butyrate improves liver glycogen metabolism in type 2 diabetes mellitus. J. Agric. Food Chem. 67, 7694\u20137705 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"824_CR88","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ptr.6486","volume":"33","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice. Phytother. Res. 33, 3140\u20133152 (2019).","journal-title":"Phytother. Res."},{"key":"824_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-021-02414-x","volume":"22","author":"L Chai","year":"2021","unstructured":"Chai, L., Luo, Q., Cai, K., Wang, K. & Xu, B. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy. BMC Nephrol. 22, 209 (2021).","journal-title":"BMC Nephrol."},{"key":"824_CR90","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2147\/JIR.S350566","volume":"15","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Gut microbiota mediates the susceptibility of mice to sepsis-associated encephalopathy by butyric acid. J. Inflamm. Res. 15, 2103\u20132119 (2022).","journal-title":"J. Inflamm. Res."},{"key":"824_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154659","volume":"111","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation. Phytomedicine 111, 154659 (2023).","journal-title":"Phytomedicine"},{"key":"824_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111157","volume":"400","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Jujuboside A through YY1\/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress. Chem. Biol. Interact. 400, 111157 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"824_CR93","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10565-022-09711-7","volume":"39","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. YY1 inactivated transcription co-regulator PGC-1\u03b1 to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis. Cell Biol. Toxicol. 39, 391\u2013413 (2023).","journal-title":"Cell Biol. Toxicol."},{"key":"824_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154703","volume":"113","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. Targeting mTOR\/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation. Phytomedicine 113, 154703 (2023).","journal-title":"Phytomedicine"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00824-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:05:39Z","timestamp":1762869939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00824-5","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}